These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 23289918

  • 1. The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex.
    Chalifoux JR, Perry N, Katz JS, Wiggins GC, Roth J, Miles D, Devinsky O, Weiner HL, Milla SS.
    J Neurosurg Pediatr; 2013 Mar; 11(3):268-73. PubMed ID: 23289918
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis.
    House PM, Holst B, Lindenau M, Voges B, Kohl B, Martens T, Lanz M, Stodieck S, Huppertz HJ.
    Epilepsy Res; 2015 Nov; 117():29-34. PubMed ID: 26370915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distribution and conspicuity of intracranial abnormalities on MR imaging in adults with tuberous sclerosis complex: A comparison of sequences including ultrafast T2-weighted images.
    Griffiths PD, Hoggard N.
    Epilepsia; 2009 Dec; 50(12):2605-10. PubMed ID: 19490046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors for mental retardation in patients with tuberous sclerosis complex.
    Chou PC, Chang YJ.
    Acta Neurol Taiwan; 2004 Mar; 13(1):10-3. PubMed ID: 15315295
    [Abstract] [Full Text] [Related]

  • 13. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition.
    Jansen FE, Vincken KL, Algra A, Anbeek P, Braams O, Nellist M, Zonnenberg BA, Jennekens-Schinkel A, van den Ouweland A, Halley D, van Huffelen AC, van Nieuwenhuizen O.
    Neurology; 2008 Mar 18; 70(12):916-23. PubMed ID: 18032744
    [Abstract] [Full Text] [Related]

  • 14. Significance of tuber size for complications of tuberous sclerosis complex.
    Pascual-Castroviejo I, Hernández-Moneo JL, Pascual-Pascual SI, Viaño J, Gutiérrez-Molina M, Velazquez-Fragua R, Quiñones Tapia D, Morales Bastos C.
    Neurologia; 2013 Mar 18; 28(9):550-7. PubMed ID: 23274119
    [Abstract] [Full Text] [Related]

  • 15. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
    Jesmanas S, Norvainytė K, Gleiznienė R, Šimoliūnienė R, Endzinienė M.
    Brain Dev; 2018 Mar 18; 40(3):196-204. PubMed ID: 29258718
    [Abstract] [Full Text] [Related]

  • 16. MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex.
    Gallagher A, Grant EP, Madan N, Jarrett DY, Lyczkowski DA, Thiele EA.
    J Neurol; 2010 Aug 18; 257(8):1373-81. PubMed ID: 20352250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
    Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domańska-Pakieła D, Jóźwiak S.
    Pediatr Neurol; 2014 Apr 18; 50(4):307-12. PubMed ID: 24507694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.